Researchers identify key player in genetic Parkinson’s
A team of researchers at the University of York have shown a protein called Rab10 plays an important role in the loss of brain cells in LRRK2-associated Parkinson’s.
Ymddiriedolwr Newydd ar gyfer Cymru - New Trustee for Wales
Mae’n bleser gan Parkinson’s UK Cymru groesawu ymddiriedolwr newydd, Elaine Evans.
Parkinson’s UK Cymru are delighted to welcome their new trustee, Elaine Evans.
We've launched a funding programme for studies into non-drug treatments for Parkinson’s
Parkinson’s UK is launching a new funding programme to support innovative studies into non-drug treatments for Parkinson’s.
Survey shows a lack of awareness of brain donation for research
Our survey of 2,000 UK adults shows that research is at risk due to a lack of awareness surrounding brain donation.
What the latest budget means for people with Parkinson's
We provide a summary of what the latest budget means for people with Parkinson's, their carers and families
Over 150 nurses in Northern Ireland hear about the Excellence Network
Nuala Campbell, our Education Adviser, presented to more than 150 nurses promoting our work and specifically the Excellence Network.
Cannabis extract may hold key to stop pain in Parkinson's
Cannabis-based compounds could be the silver bullet to relieve pain for people with Parkinson’s according to the largest ever study into pain and the condition.
Cymru yn cynnal cyfarfod cyntaf y Rhwydwaith Rhagoriaeth ar draws y wlad - Wales holds it's first country-wide Excellence Network meeting
Daeth 80 o weithwyr proffesiynol ym maes iechyd a gofal cymdeithasol a phobl sydd wedi eu heffeithio gan glefyd Parkinson ynghyd yng Nghaerdydd ar 23 Ionawr ar gyfer cyfarfod cyntaf o Rwydwaith Rhagoriaeth Cymru Gyfan.
80 health and social care professionals and people affected by Parkinson’s came together in Cardiff on January 23 for the first All Wales Excellence Network meeting.
Potential treatment for dyskinesia in Parkinson’s
Results from a one-year project, funded through the Parkinson’s Virtual Biotech, suggest that NLX-112 has potential as a future treatment for reducing dyskinesia and improving movement symptoms of Parkinson’s.
The latest news on the Sinemet supply.